https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-biologics-concludes-integration-of-acquired-biosimilars-business-in-120-countries/ 2025-08-06T18:05:45+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-ranked-no-8-among-science-magazines-best-employers-in-global-biotech-and-pharma-sector/ 2025-08-06T18:07:04+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/bbl-continues-to-expand-global-footprint-completes-biosimilars-business-in-usa/ 2025-08-07T04:41:40+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/after-five-years-of-successful-experience-hulio-available-in-the-united-states/ 2025-08-07T04:43:13+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-biologics-announces-new-dermatology-data-to-be-presented-at-eadv-congress-2024/ 2025-08-07T04:51:51+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-continues-to-be-among-science-magazines-top-10-global-employers-list/ 2025-08-07T04:53:56+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-biologics-completes-one-year-as-an-integrated-global-biosimilars-enterprise/ 2025-08-07T04:55:59+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-biologics-to-present-at-the-43rd-annual-j-p-morgan-healthcare-conference/ 2025-08-07T04:56:41+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-biologics-receives-complete-response-letter-from-u-s-fda-for-biosimilar-insulin-aspart/ 2025-08-18T07:27:09+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/u-s-fda-completes-two-cgmp-inspections-at-biocon-biologics-insulins-facility-in-malaysia/ 2025-08-18T07:29:18+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/bbl-obtains-us-fda-approval-for-biosimilar-aflibercept-for-yesafili-enters-us-ophthalmology-market/ 2025-08-19T07:22:47+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-biologics-moves-into-new-north-american-headquarters-in-bridgewater-new-jersey/ 2025-08-19T07:25:41+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-biologics-announces-results-of-aflibercept-switching-study-at-american-academy-of-ophthalmology-annual-meeting/ 2025-08-19T07:27:00+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-biologics-secures-us-market-entry-date-for-bmab-1200-a-proposed-biosimilar-to-stelara/ 2025-08-19T07:32:51+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/us-fda-approves-biocon-biologics-yesintek-bmab-1200-biosimilar-to-jjs-stelara-ustekinumab/ 2025-08-19T07:37:06+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/usfda-classifies-biocon-biologics-biocon-park-site-in-bengaluru-india/ 2025-08-19T07:38:48+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-biologics-drug-substance-facility-in-bengaluru-classified-as-voluntary-action-indicated-vai/ 2025-08-19T07:40:37+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/company-statement-on-bbevacizumab/ 2025-08-19T08:32:10+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/us-fda-completes-inspection-at-biocon-biologics-insulins-facility-at-johor-bahru-malaysia/ 2025-08-19T08:34:05+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/us-fda-completes-inspection-at-biocon-biologics-facilities-at-biocon-park-bengaluru-india/ 2025-08-19T08:35:58+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/fr/company-statement-on-aflibercept/ 2025-08-19T08:38:35+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/fr/update-on-u-s-fda-inspection-at-biocon-biologics-manufacturing-facility-in-johor-malaysia/ 2025-08-19T08:40:37+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/unifying-standards-the-need-for-streamlined-biosimilar-development/ 2025-08-20T12:54:31+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/uwe-gudat-m-d-new-biosimilar-data-bring-reassurance-for-patients-with-psoriasis/ 2025-08-21T05:11:44+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/a-conversation-with-joshua-salsi-head-of-north-america-biocon-biologics/ 2025-08-21T05:12:05+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/panelists-stress-stakeholder-education-to-build-confidence-in-biosimilars/ 2025-08-21T05:12:54+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/grxbiosims-panelists-discuss-regulatory-shifts-in-biosimilar-interchangeability/ 2025-08-21T05:13:06+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/new-campaign-targets-talent-by-showing-what-somerset-county-has-to-offer/ 2025-08-21T05:13:16+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/quiet-giant-biocon-sets-out-vision-for-biosimilars-2/ 2025-08-21T05:13:24+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/the-future-of-biosimilars-qa-with-matt-erick/ 2025-08-21T05:14:32+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/generics-bulletin-explains-after-humira-biosimilars-will-it-be-groundhog-day-for-stelara/ 2025-08-21T05:14:40+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/fda-approves-biocon-biologics-yesafili/ 2025-08-21T05:14:49+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biosimilar-uptake-appears-to-finally-be-on-the-upswing-and-biocon-biologics-is-betting-on-the-sectors-future/ 2025-08-21T05:14:56+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/uwe-gudat-m-d-new-biosimilar-data-bring-reassurance-for-patients-with-psoriasis-2/ 2025-08-21T05:15:04+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/taking-control-of-our-destiny-biocon-biologics-ceo-tambe-celebrates-european-viatris-integration/ 2025-08-21T05:15:11+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-biologics-makes-donation-to-insulin-for-life/ 2025-08-21T05:15:32+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/wp-content/uploads/2025/04/Canada_Kirsty-Brand-logo-en-3.png https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/wp-content/uploads/2025/08/Insulin-image.jpg https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/wp-content/uploads/2025/08/Matthew-Edward-Erick.png https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-biologics-breaks-billion-dollar-barrier-with-58-rise-in-annual-revenue/ 2025-08-21T11:00:56+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/wp-content/uploads/2025/04/Canada_Kirsty-Brand-logo-en-3.png https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/wp-content/uploads/2024/07/Shreehas-P-Tambe.jpg https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-biologics-opens-north-america-headquarters-in-new-jerseys-biopharma-corridor/ 2025-08-22T10:17:36+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/wp-content/uploads/2025/04/Canada_Kirsty-Brand-logo-en-3.png https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/wp-content/uploads/2025/04/Image1-1024x683.jpg https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/wp-content/uploads/2025/04/BioconBiologics_Proofs_1604-min-Copy-1024x486.jpg https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/wp-content/uploads/2025/04/Image2.jpg https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/wp-content/uploads/2025/04/BioconBiologics_Proofs_1159-v1-1536x745-1-1024x497.jpg https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/wp-content/uploads/2025/04/Joshua-Salsi-1.jpg https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-biologics-launches-yesintek-ustekinumab-kfce-biosimilar-to-stelara-in-the-united-states/ 2025-10-03T07:57:24+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/biocon-biologics-announces-new-dermatology-data-to-be-presented-at-eadv-congress-2024-2/ 2025-10-03T10:01:14+00:00 https://dev-wp-bioconbiologics-eu.bioconbiologicsit.com/fr/u-s-fda-classifies-biocon-biologics-site-in-johor-bahru-malaysia-as-voluntary-action-indicated-vai/ 2025-10-03T10:04:16+00:00